Home › Neuroendocrine Tumors › Arizona › Phoenix
Neuroendocrine Tumors clinical trials in Phoenix, AZ
4 studies for Neuroendocrine Tumors are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Mayo Clinic Hospital, Phoenix
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Phoenix
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Phoenix Childrens Hospital, Phoenix
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, Phoenix
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- Philadelphia, PA11 studies
- Rochester, MN9 studies
- Salt Lake City, UT8 studies
- Columbus, OH8 studies
- St. Louis, MO8 studies
- Houston, TX8 studies
- Cleveland, OH7 studies
- Cedar Rapids, IA7 studies
- Chicago, IL7 studies
- New York City, NY7 studies
- Miami, FL7 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.